Bilateral vs. Unilateral Erector Spinae Plane Block
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03781687 |
|
Recruitment Status :
Completed
First Posted : December 20, 2018
Last Update Posted : November 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Postoperative Pain Cholecystitis; Gallstone | Procedure: Bilateral ESP Block Procedure: Unilateral ESP Block Device: Intravenous Morphine patient controlled analgesia device | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 90 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Double (Care Provider, Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Bilateral vs. Unilateral Erector Spinae Plane Block for Laparoscopic Cholecystectomy; A Randomised Controlled Trial |
| Actual Study Start Date : | January 2, 2019 |
| Actual Primary Completion Date : | June 28, 2019 |
| Actual Study Completion Date : | June 29, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Bilateral
Bilateral ESP block will be performed
|
Procedure: Bilateral ESP Block
Bilateral ESP Block will be performed at T8 Device: Intravenous Morphine patient controlled analgesia device 24 hour morphine consumption will be recorded |
|
Active Comparator: Unilateral
Unilateral ESP block will be performed
|
Procedure: Unilateral ESP Block
Unilateral ESP Block will be performed at T8 (right side) Device: Intravenous Morphine patient controlled analgesia device 24 hour morphine consumption will be recorded |
- Morphine consumption [ Time Frame: preoperative 24th hour ]Morphine consumption will be recorded
- Numeric Rating Scale [ Time Frame: postoperative 24th hour ]A NRS involves asking the patient to rate his or her pain from 0 to 10 (11 point scale) with the understanding that 0 is equal to no pain and 10 is equal to worst possible pain.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ASA I-II patients
- Pateints undergoing elective laparoscopic cholecystectomy
Exclusion Criteria:
- obesity (body mass index >35 kg/m2)
- infection of the skin at the site of needle puncture area
- patients with known allergies to any of the study drugs
- coagulopathy
- recent use of analgesic drugs
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03781687
| Turkey | |
| Kocaeli University Hospital | |
| İzmit, Kocaeli, Turkey, 41340 | |
| Principal Investigator: | Can Aksu | Kocaeli Üniversitesi Tıp Fakültesi |
| Responsible Party: | Can AKSU, Assistant Professor, Kocaeli University |
| ClinicalTrials.gov Identifier: | NCT03781687 |
| Other Study ID Numbers: |
KIA 2018/488 |
| First Posted: | December 20, 2018 Key Record Dates |
| Last Update Posted: | November 25, 2019 |
| Last Verified: | November 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
erector spinae plane block postoperative pain laparoscopic cholecystectomy |
|
Cholecystitis Gallstones Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations Gallbladder Diseases Biliary Tract Diseases Digestive System Diseases Cholelithiasis |
Cholecystolithiasis Calculi Pathological Conditions, Anatomical Morphine Analgesics, Opioid Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |

